M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Health Canada OKs new indication for Boehringer Ingelheim's MICARDIS
26 November 2009 - Boehringer Ingelheim Canada, part of German Boehringer Ingelheim, said today that Health Canada has approved MICARDIS (telmisartan) as treatment to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing...
If you want to view the full text of this story, you must first purchase archive retrieval credits.